T Sakai

Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.

Laurent Brossay, Olga V. Naidenko, Nicolas Burdin et al. · PubMed · 1998 · 140 citations

Nk T Cells, Structural Requirements, Complete Truncation +11

Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells.

Masaru Kamishohara, Hiroyuki Kawai, T Sakai et al. · PubMed · 1994 · 32 citations

Antitumor Activity, Chemoprevention Strategy, Pathology +16

A new in vivo model for studying invasion and metastasis of esophageal squamous cell carcinoma

Tadashi Furihata, T Sakai, Hiroshi Kawamata et al. · International Journal of Oncology · 2001 · 22 citations

Orthotopic Inoculation Model, Esophagus, Esophageal Cancer +14

Discovery and structure–activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors

Tomomi Noguchi‐Yachide, T Sakai, Yuichi Hashimoto et al. · Bioorganic & Medicinal Chemistry · 2015 · 20 citations · Full text

Medicinal Chemistry, N6-benzoyladenine Derivatives, Derivative (Chemistry) +9

Design, synthesis and structure–activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton

T Sakai, Yotaro Matsumoto, Minoru Ishikawa et al. · Bioorganic & Medicinal Chemistry · 2014 · 20 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +11